Format

Send to

Choose Destination
See comment in PubMed Commons below
Chem Biol. 2012 Jan 27;19(1):155-63. doi: 10.1016/j.chembiol.2011.12.010.

Identification of biologically active PDE11-selective inhibitors using a yeast-based high-throughput screen.

Author information

1
Biology Department, Boston College, Chestnut Hill, MA 02467, USA.

Abstract

The biological roles of cyclic nucleotide phosphodiesterase 11 (PDE11) enzymes are poorly understood, in part due to the lack of selective inhibitors. To address the need for such compounds, we completed an ~200,000 compound high-throughput screen (HTS) for PDE11 inhibitors using a yeast-based growth assay, and identified 4 potent and selective PDE11 inhibitors. One compound, along with two structural analogs, elevates cAMP and cortisol levels in human adrenocortical cells, consistent with gene association studies that link PDE11 activity to adrenal function. As such, these compounds can immediately serve as chemical tools to study PDE11 function in cell culture, and as leads to develop therapeutics for the treatment of adrenal insufficiencies. Our results further validate this yeast-based HTS platform for the discovery of potent, selective, and biologically active PDE inhibitors.

PMID:
22284362
DOI:
10.1016/j.chembiol.2011.12.010
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center